FDAs decision to halt production With the manufacturer Novo Nordisk now able to produce enough medication such that it is readily available, the FDA has ordered all pharmacies to stop making or selling compounded semaglutide
Medications such as semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro) can contribute to improved fertility in women with obesity, partly as a result of weight loss and improved hormonal and metabolic function
Release mechanisms of major DAMPs
With summer underway, many Americans report experiencing extreme weather in the past month, though this is down relative to last year
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 276,54 per year only 23,05 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF